Natalie Sacks lands at Harpoon after jumping ship at Aduro; European biotech financings surge
→ We now know where Natalie Sacks was headed after jumping ship at Aduro $ADRO.
The chief medical officer changed hats but kept the same job, joining South San Francisco-based Harpoon Therapeutics, which has been working on T cell engaging therapies.
Sacks left Aduro exactly two years after joining the biotech. And she left just days ahead of a revamp at Aduro that followed J&J’s decision to abandon its long running pair of partnerships at the company, valued at up to $1.2 billion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.